Please fill out the form below to receive an update as soon as this new functionality is available.
The ongoing investigation is looking into the following claims against the manufacturers: Defective Product Design Defective Product Manufacturing Improper Labeling & Failure to Warn Patients for Risk of Severe Gastrointestinal Problems Medical Malpractice Committed by Plaintiffs' Doctors who Prescribed the Drug Off-label for Weight Loss are a separate cause of action against different defendants Personal injury lawsuits for gastroparesis are the latest legal development associated with the GLP-1 receptor agonist drug class, which includes the semaglutide medications Ozempic, Wegovy, and Rybelsus
The fine-gauge construction (particularly 30G and 31G) and small barrel volumes (0.3 mL) make them well-suited for low-volume subcutaneous administration of peptide compounds
It is marketed as a type 2 diabetes medication with the brand name Mounjaro and as a weight loss drug known as Zepbound
Even in patients without genetic mutations, the Th2 inflammatory environment suppresses filaggrin expression epigenetically
Huang R, Xu Y, Lu X, Tang X, Lin J, Cui K, et al
